These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30148769)

  • 1. Tattoo-associated complications of metastatic melanoma treated with dabrafenib and trametinib.
    Laske J; Meier F; Bauer A; Beissert S; Garzarolli M
    Melanoma Res; 2018 Oct; 28(5):485-487. PubMed ID: 30148769
    [No Abstract]   [Full Text] [Related]  

  • 2. Pomalidomide, dabrafenib mesylate, and trametinib dimethyl sulfoxide.
    Hussar DA; Kaminski JL
    J Am Pharm Assoc (2003); 2013; 53(5):550-8. PubMed ID: 24030134
    [No Abstract]   [Full Text] [Related]  

  • 3. Vemurafenib/dabrafenib and trametinib.
    Rissmann R; Hessel MH; Cohen AF
    Br J Clin Pharmacol; 2015 Oct; 80(4):765-7. PubMed ID: 25847075
    [No Abstract]   [Full Text] [Related]  

  • 4. Dabrafenib plus trametinib in BRAF K601E-mutant melanoma.
    Rogiers A; Thomas D; Vander Borght S; van den Oord JJ; Bechter O; Dewaele M; Rambow F; Marine JC; Wolter P
    Br J Dermatol; 2019 Feb; 180(2):421-422. PubMed ID: 30248172
    [No Abstract]   [Full Text] [Related]  

  • 5. Dabrafenib plus Trametinib: a Review in Advanced Melanoma with a BRAF (V600) Mutation.
    Dhillon S
    Target Oncol; 2016 Jun; 11(3):417-28. PubMed ID: 27246822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemophagocytic lymphohistiocytosis in advanced melanoma treated with dabrafenib and trametinib combination: two cases.
    Samaran Q; Belakebi D; Theret S; Becquart O; Girard C; Du Thanh A; Guillot B; Lesage C; Dereure O
    Melanoma Res; 2020 Oct; 30(5):519-523. PubMed ID: 32784332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dabrafenib (Tafinlar) and trametinib (Mekinist) metastatic melanoma.
    Med Lett Drugs Ther; 2013 Aug; 55(1422):62-3. PubMed ID: 23917385
    [No Abstract]   [Full Text] [Related]  

  • 8. Effective treatment with Dabrafenib and Trametinib for a BRAF-mutated metastatic dedifferentiated malignant spindle cell neoplasm.
    Escandell I; Cabezas M; Martín JM; Terradez L; Pinazo MI
    J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1224-6. PubMed ID: 25917403
    [No Abstract]   [Full Text] [Related]  

  • 9. KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in
    Ferrucci PF; Di Giacomo AM; Del Vecchio M; Atkinson V; Schmidt H; Schachter J; Queirolo P; Long GV; Stephens R; Svane IM; Lotem M; Abu-Amna M; Gasal E; Ghori R; Diede SJ; Croydon ES; Ribas A; Ascierto PA;
    J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33361337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sweet syndrome in metastatic melanoma during treatment with dabrafenib and trametinib.
    Scarfì F; Melotti B; Veronesi G; Ravaioli GM; Baraldi C; Lambertini M; Patrizi A; Dika E
    Australas J Dermatol; 2019 Aug; 60(3):e242-e243. PubMed ID: 30724336
    [No Abstract]   [Full Text] [Related]  

  • 11. [A woman with a skin lesion suspected for melanoma].
    Post NF; Huis In 't Veld E; Crijns MB
    Ned Tijdschr Geneeskd; 2020 Feb; 164():. PubMed ID: 32267633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connective tissue panniculitis and vitiligo in a patient with stage IV melanoma achieving complete response to dabrafenib and trametinib combination therapy.
    Gargiulo L; Chiara Tronconi M; Grimaudo MS; Pavia G; Valenti M; Manara S; Costanzo A; Borroni RG
    Melanoma Res; 2021 Dec; 31(6):586-588. PubMed ID: 34620756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis following dabrafenib and trametinib for metastatic melanoma.
    Zaloum A; Falet JR; Elkrief A; Chalk C
    Neurology; 2020 Feb; 94(7):322-323. PubMed ID: 31888971
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring
    Odogwu L; Mathieu L; Blumenthal G; Larkins E; Goldberg KB; Griffin N; Bijwaard K; Lee EY; Philip R; Jiang X; Rodriguez L; McKee AE; Keegan P; Pazdur R
    Oncologist; 2018 Jun; 23(6):740-745. PubMed ID: 29438093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of BRAF
    Yamamoto G; Sakakibara-Konishi J; Ikari T; Kitai H; Mizugaki H; Asahina H; Kikuchi E; Shinagawa N
    J Thorac Oncol; 2019 May; 14(5):e97-e99. PubMed ID: 31027751
    [No Abstract]   [Full Text] [Related]  

  • 16. Repeated complete response with long-term control of BRAF-mutant melanoma by multiple rechallenges with dabrafenib plus trametinib.
    Sasaki K; Nakamura Y; Baba N; Teramoto Y; Yamamoto A
    Eur J Cancer; 2020 Nov; 139():37-40. PubMed ID: 32957012
    [No Abstract]   [Full Text] [Related]  

  • 17. Dabrafenib and trametinib, alone and in combination for BRAF-mutant metastatic melanoma.
    Menzies AM; Long GV
    Clin Cancer Res; 2014 Apr; 20(8):2035-43. PubMed ID: 24583796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uveitis and Papillitis in the Setting of Dabrafenib and Trametinib Therapy for Metastatic Melanoma: A Case Report.
    Lim J; Lomax AJ; McNeil C; Harrisberg B
    Ocul Immunol Inflamm; 2018; 26(4):628-631. PubMed ID: 27892777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare BRAF T599dup mutation conferring sensitivity to BRAF inhibitor in a patient with metastatic melanoma.
    Marchand A; Tallet A; Collin C; Cormier B; Venel Y; Miquelestorena-Standley E; Machet L
    Br J Dermatol; 2018 Aug; 179(2):528-529. PubMed ID: 29494756
    [No Abstract]   [Full Text] [Related]  

  • 20. Durable Response to Combination of Dabrafenib and Trametinib in BRAF V600E-Mutated Non-small-cell Lung Cancer.
    Pervere LM; Rakshit S; Schrock AB; Miller VA; Ali SM; Velcheti V
    Clin Lung Cancer; 2017 May; 18(3):e211-e213. PubMed ID: 28024926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.